How Long After Radioiodine — Can You Try for a Baby?

For women, most thyroid teams advise waiting 6 to 12 months after a radioiodine (I-131) dose before trying to conceive, in line with NCCN thyroid-carcinoma and American Thyroid Association guidance. For men, the usual advice is around 4 months. The range exists because the wait is not one rule but three overlapping ones: your thyroid hormone replacement dose needs to be stable before pregnancy raises the requirement, your first follow-up scans and blood tests need to be complete, and any decision about a further dose is better made before a pregnancy than during one. Ask your own team for the number that applies to your dose and your plan.

Yes. Men are usually advised to wait about 4 months before trying to father a child, which is shorter than the 6 to 12 months commonly advised for women. The reason is different too. For men the interval is set by the sperm production cycle, which takes roughly two to three months from start to finish, so waiting about four months allows sperm formed during and just after the dose to be cleared and replaced. Men who are scheduled for repeated or high cumulative radioiodine activity should ask their team about sperm banking before the first dose, since the conversation is far easier to have in advance.

For most people treated with a standard radioiodine dose for thyroid cancer, no lasting effect on fertility is expected, and guideline bodies including NCCN and the American Thyroid Association do not describe permanent infertility as a usual outcome at these activity levels. Temporary changes are common and expected: many women notice irregular or missed periods in the first several months, and many men have a temporary dip in sperm production. Both usually settle. The picture can differ with repeated doses and higher cumulative activity, so if more than one dose is planned, raise fertility with your team before treatment starts rather than after.

Studies followed by NCCN and the American Thyroid Association have not shown a consistent increase in birth defects, stillbirth or childhood cancer in babies conceived after the advised waiting period. What has been reported is a temporary rise in miscarriage among pregnancies that begin in the first year after a dose, and that observation is one of the practical reasons the waiting interval exists at all. An uncontrolled thyroid hormone replacement dose in early pregnancy is its own separate risk, independent of the radioiodine. Both are managed the same way: wait the interval your team gives you, get your replacement dose settled first, and tell your antenatal team about your treatment history.

Tell your oncology team straight away, and tell your antenatal team as well. An earlier-than-advised pregnancy is not automatically a problem and is not a reason to panic, but it does change the plan. Your thyroid hormone replacement will usually need reviewing early, because pregnancy raises the amount your body needs. Any further radioiodine dose or follow-up scan that was being considered will be deferred, since neither is given during pregnancy. What matters most is that the decision is made with your full history in front of the team, rather than guessed at home or delayed out of worry about being told off.

Not for the child you were feeding at the time of the dose. Breastfeeding has to stop several weeks before a radioiodine dose, because breast tissue actively takes up iodine, and it cannot be restarted for that baby afterwards. This is a firm rule, not a cautious one, and it is one reason teams try to time a dose around a family's feeding plans where the cancer plan allows it. Breastfeeding a future baby, conceived after the advised waiting period, is generally expected to be possible. Confirm the specific timings with the nuclear medicine team handling your dose.